Surgery is rarely indicated in these circumstances. Infrequently, benign liver tumors are diagnosed because of symptoms or complications, and require urgent management including surgery as a major ...

Liver biochemistry (usually normal in cases of benign, uncomplicated tumors), viral serologies, and tumor markers are useful for excluding liver disease or with atypical presentations. The ...

A group of researchers at VCU Massey Comprehensive Cancer Center was awarded $13 million by the National Cancer Institute.

Biomarker NBR1 shows promise in predicting liver cancer patients' response to immunotherapy, potentially improving treatment ...

Currently, there are a few available treatment options for liver cancer, including a combination of immunotherapies and a class of drugs known as tyrosine kinase inhibitors (TKIs), but their long-term ...

Doctors at the Cleveland Clinic are now using a new non-invasive approach to kill the tumors and keep patients alive.

A group of highly experienced researchers at VCU Massey Comprehensive Cancer Center was awarded more than $13 million through ...

The #HOPE4LIVER trials, testing the safety efficacy of histotripsy as a treatment for primary and metastatic liver tumors, met its goals for technical success and safety. The result, published in ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit ...

Researchers at Weill Cornell Medicine have made a breakthrough in the fight against liver cancer, by identifying a biomarker ...

Hoag announced today a new technology using ultrasound energy to precisely destroy liver tumors in a single outpatient visit.